Nakayama T
Hokkaido Igaku Zasshi. 1985 Sep;60(5):643-52.
In this study, HLA antigen frequencies of 37 patients with Behçet's disease were investigated. A significant association with HLA-B 51 was confirmed (56.8% compared with 10.0% controls, P less than 0.0001, relative risk (R.R.) = 11.8). Furthermore, significant increases of HLA-DRw 52 (86.1% compared with 50.9% controls, Pc less than 0.05, R.R. = 6.0) and a new specificity detected by a monoclonal antibody, HU-39 (61.1% compared with 25.5% controls, Pc less than 0.05, R.R. = 4.6) were also observed. The serologic specificity of HU-39 was DRw 8 + DRw 12, which has never been defined using alloantisera. Immunochemical analyses indicated that the determinant recognized by HU-39 was borne on the HLA-DR molecule, not on the HLA-DQ molecule. These results suggest that not only HLA-B locus antigens but also HLA-D region antigens, particularly HLA-DR antigens, play a part in the pathogenesis of Behçet's disease. In addition, the usefulness of this monoclonal antibody as tissue typing reagent and the application of monoclonal antibodies to the analysis of disease susceptibility were discussed.
在本研究中,对37例白塞病患者的HLA抗原频率进行了调查。证实了与HLA - B51存在显著关联(患者组为56.8%,对照组为10.0%,P小于0.0001,相对危险度(R.R.)= 11.8)。此外,还观察到HLA - DRw52显著增加(患者组为86.1%,对照组为50.9%,Pc小于0.05,R.R. = 6.0),以及一种由单克隆抗体HU - 39检测到的新特异性抗原增加(患者组为61.1%,对照组为25.5%,Pc小于0.05,R.R. = 4.6)。HU - 39的血清学特异性为DRw8 + DRw12,这是从未用同种抗血清定义过的。免疫化学分析表明,HU - 39识别的决定簇存在于HLA - DR分子上,而非HLA - DQ分子上。这些结果提示,不仅HLA - B位点抗原,而且HLA - D区抗原,特别是HLA - DR抗原,在白塞病的发病机制中起作用。此外,还讨论了这种单克隆抗体作为组织分型试剂的实用性以及单克隆抗体在疾病易感性分析中的应用。